• Malcisbo has been selected as one of the Top 100 startups in Switzerland

    19 October 2011

    Excellent ranking on place 9 as best vaccine startup in the Top 100 Swiss startup survey.

  • Malcisbo closes seed financing round

    19 September 2011

    Malcisbo has successfully closed its seed financing round. The initial target of CHF 2.4 Mio. was substantially exceeded. Private investors, Business Angels, Zürcher Kantonalbank Startup Finance and Redalpine Venture Partners AG have invested in total a sum of CHF 3.6 Mio in the company. In parallel the company was granted a substantial research contribution by CTI.

  • Winner W.A. de Vigier Foundation`s Business plan competition

    29 June 2011

    Malcisbo wins W.A. de Vigier`s business plan competition.

  • Swiss Venture Guide 2011

    01 May 2011

    Malcisbo is presented in Swiss Venture Guide 2011. This guide for Swiss high tech companies is a joint effort of CTI Invest & CTI and reports about Malcisbo as one of 10 companies on the way to success.

  • Venture Leaders

    06 April 2011

    Malcisbo wins venture leaders to participate in a business development program in Boston.

<1 2 3 4 5>

Latest News

  • 26 November 2018

    VetBioNet grant

    Malcisbo wins a grant to perform an APP challenge trial in a BLS3 facility.

  • 25 January 2017

    Malcisbo has been selected as emerging company to present at the Animal Health Investment Forum in London (Feb 2017)

  • 21 December 2016

    Malcisbo participates in a CTI-funded research project on the development of a vaccine against APP.